• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Biolinq names new CEO

November 12, 2020 By Sean Whooley

BiolinqWearable biosensor technology developer Biolinq announced today that it named Richard Yang as its new CEO.

San Diego-based Biolinq, which develops biosensor platforms to measure continuous glucose for managing diabetes, among other clinical conditions, said in a news release that Yang is a veteran of more than 20 years with time spent at top-tier medical device companies.

Biolinq co-founder Jared Tangney, who previously served as CEO, will now take on the role of president & chief operating officer as Yang takes over the CEO position.

“We’ve had the pleasure of getting to know Rich well over the past several years and we’re thrilled to welcome him on board to lead Biolinq to the next stage of our development,” Tangney said in the release. “Throughout his career, Rich has repeatedly helped lead companies with groundbreaking technology to category-defining status.”

Yang previously worked with MiniMed insulin pumps before working in Medtronic’s diabetes segment. Most recently, he spent almost a decade at Dexcom in an executive leadership role.

“Biolinq was a natural draw for me, particularly due to its innovative approach to dermal sensing and profound microneedle array technology that has the potential to significantly transform the user experience,” Yang said. “It’s an honor to help build upon the vision of the company’s founders and I look forward to advancing new technologies that will serve the diabetes community and beyond.”

Filed Under: Diabetes, Diagnostics, Featured, Personnel Tagged With: biolinq

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS